Jennifer E. Koblinski

3.7k total citations
71 papers, 2.7k citations indexed

About

Jennifer E. Koblinski is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jennifer E. Koblinski has authored 71 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 27 papers in Oncology and 19 papers in Cancer Research. Recurrent topics in Jennifer E. Koblinski's work include Cell Adhesion Molecules Research (16 papers), Protease and Inhibitor Mechanisms (10 papers) and Cancer Cells and Metastasis (7 papers). Jennifer E. Koblinski is often cited by papers focused on Cell Adhesion Molecules Research (16 papers), Protease and Inhibitor Mechanisms (10 papers) and Cancer Cells and Metastasis (7 papers). Jennifer E. Koblinski collaborates with scholars based in United States, Japan and Australia. Jennifer E. Koblinski's co-authors include Bonnie F. Sloane, Mamoun Ahram, Hynda K. Kleinman, Irina Arnaoutova, Jay George, Gabriel Benton, Kamiar Moin, Hidayatullah G. Munshi, Mikhail G. Dozmorov and Madhavi Puchalapalli and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Jennifer E. Koblinski

67 papers receiving 2.6k citations

Peers

Countries citing papers authored by Jennifer E. Koblinski

Since Specialization

Citations

This map shows the geographic impact of Jennifer E. Koblinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer E. Koblinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer E. Koblinski more than expected).

Fields of papers citing papers by Jennifer E. Koblinski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer E. Koblinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer E. Koblinski. The network helps show where Jennifer E. Koblinski may publish in the future.

Co-authorship network of co-authors of Jennifer E. Koblinski

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer E. Koblinski. A scholar is included among the top collaborators of Jennifer E. Koblinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer E. Koblinski. Jennifer E. Koblinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A trackable trinuclear platinum complex for breast cancer treatment 2025 ·Nucleic Acids Research ·(unknown), Creina Slator, Raphael Enoque Ferraz de Paiva, (unknown), (unknown), Sriram KK, (unknown), (unknown), (unknown), Katarzyna Mnich, Erica J. Peterson, Bin Hu, Jennifer E. Koblinski, Afshin Samali, Vickie McKee, Alice L. B. Pyne, Fredrik Westerlund, Nicholas P. Farrell, Andrew Kellett	1
2	High dose acetaminophen re-polarizes CD11b+ cells in the tumor microenvironment towards an activated macrophage phenotype 2025 ·Neoplasia ·(unknown), (unknown), (unknown), (unknown), (unknown), Adam Khader, (unknown), (unknown), Jennifer E. Koblinski, (unknown), Rebecca Martin, Bhaumik B. Patel, Joseph W. Landry, (unknown)	0
3	Oncogenic Mutant p53 Sensitizes Non–Small Cell Lung Cancer Cells to Proteasome Inhibition via Oxidative Stress–Dependent Induction of Mitochondrial Apoptosis 2024 ·Cancer Research Communications ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jennifer E. Koblinski, (unknown), Swati Palit Deb, (unknown), Jorge J. Nieva, Senthil K. Radhakrishnan, Hisashi Harada, Steven R. Grossman	3
4	The Innate Immune System and the TRAIL–Bcl-XL Axis Mediate a Sex Bias in Lung Cancer and Confer a Therapeutic Vulnerability in Females 2024 ·Cancer Research ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Chunqing Guo, (unknown), Xiaoyan Deng, Anthony C. Faber, (unknown), Dipankar Bandyopadhyay, Xiang‐Yang Wang, Alexander Neuwelt, Jennifer E. Koblinski, Paula D. Bos, Howard Li, Rebecca Martin, Joseph W. Landry	2
5	Antitumor active trans‑platinum complexes through metabolic stability and enhanced cellular accumulation 2023 ·Journal of Inorganic Biochemistry ·Vijay Menon, (unknown), Daniel E. Lee, Erica J. Peterson, Jennifer E. Koblinski, Nicholas P. Farrell	0
6	High-Dose Acetaminophen with N-acetylcysteine Rescue Inhibits M2 Polarization of Tumor-Associated Macrophages 2023 ·Cancers ·(unknown), (unknown), (unknown), Howard Li, Tytus Bernaś, Jennifer E. Koblinski, Joseph W. Landry, (unknown), Bhaumik B. Patel, Alexander Neuwelt	5
7	Genomic screening reveals ubiquitin-like modifier activating enzyme 1 as a potent and druggable target in c-MYC-high triple negative breast cancer models 2022 ·PNAS Nexus ·Sheeba Jacob, (unknown), Jinyang Cai, Konstantinos V. Floros, (unknown), (unknown), (unknown), Mohammad A. Alzubi, Charles T. Jakubik, (unknown), Madhavi Puchalapalli, (unknown), Mikhail G. Dozmorov, Sosipatros A. Boikos, Bin Hu, J. Chuck Harrell, Cyril H. Benes, Jennifer E. Koblinski, Carlotta Costa, Anthony C. Faber	6
8	MYCN -Amplified Neuroblastoma Is Addicted to Iron and Vulnerable to Inhibition of the System Xc-/Glutathione Axis 2021 ·Cancer Research ·Konstantinos V. Floros, Jinyang Cai, Sheeba Jacob, Richard Kurupi, (unknown), (unknown), (unknown), Krista M. Powell, (unknown), Bin Hu, Madhavi Puchalapalli, Sivapriya Ramamoorthy, (unknown), Janina P. Lewis, Mikhail G. Dozmorov, John Glod, Jennifer E. Koblinski, Sosipatros A. Boikos, Anthony C. Faber	104
9	Pharmaceutical Interference of the EWS-FLI1–driven Transcriptome By Cotargeting H3K27ac and RNA Polymerase Activity in Ewing Sarcoma 2021 ·Molecular Cancer Therapeutics ·Daniel A.R. Heisey, Sheeba Jacob, Timothy L. Lochmann, Richard Kurupi, (unknown), (unknown), (unknown), (unknown), Jennifer E. Koblinski, Mikhail G. Dozmorov, Sosipatros A. Boikos, Cyril H. Benes, Anthony C. Faber	11
10	Anillin regulates breast cancer cell migration, growth, and metastasis by non-canonical mechanisms involving control of cell stemness and differentiation 2020 ·Breast Cancer Research ·Dongdong Wang, Nayden G. Naydenov, Mikhail G. Dozmorov, Jennifer E. Koblinski, Andrei I. Ivanov	38
11	Inhibition of the Activity of Cyclophilin A Impedes Prolactin Receptor-Mediated Signaling, Mammary Tumorigenesis, and Metastases 2020 ·iScience ·(unknown), Justin M. Craig, Jennifer E. Koblinski, Charles V. Clevenger	7
12	Targeting the Metabolic Plasticity of Multiple Myeloma with FDA-Approved Ritonavir and Metformin 2014 ·Clinical Cancer Research ·(unknown), Richa Bajpai, (unknown), Kehinde Adekola, Irawati Kandela, Changyong Wei, Seema Singhal, Jennifer E. Koblinski, Noopur Raje, Steven T. Rosen, Mala Shanmugam	123
13	Matrigel: From discovery and ECM mimicry to assays and models for cancer research 2014 ·Advanced Drug Delivery Reviews ·Gabriel Benton, Irina Arnaoutova, Jay George, Hynda K. Kleinman, Jennifer E. Koblinski	361
14	Enhanced Metastasis Suppression by Targeting TRAIL Receptor 2 in a Murine Model of Triple-Negative Breast Cancer 2011 ·Clinical Cancer Research ·Dmitry Malin, Feng Chen, (unknown), Jennifer E. Koblinski, Vincent L. Cryns	44
15	Urinary-Type Plasminogen Activator Receptor/α3β1 Integrin Signaling, Altered Gene Expression, and Oral Tumor Progression 2010 ·Molecular Cancer Research ·Supurna Ghosh, Jennifer E. Koblinski, Jeffrey J. Johnson, Yueying Liu, Aaron C. Ericsson, J. Wade Davis, Zonggao Shi, Matthew J. Ravosa, Susan E. Crawford, Shellaine R. Frazier, M. Sharon Stack	20
16	The WW-HECT protein Smurf2 interacts with the Docking Protein NEDD9/HEF1 for Aurora A activation 2010 ·Cell Division ·Finola E. Moore, Evan C. Osmundson, Jennifer E. Koblinski, Elena N. Pugacheva, Erica A. Golemis, Dipankar Ray, Hiroaki Kiyokawa	19
17	Slug is a downstream mediator of transforming growth factor‐β1‐induced matrix metalloproteinase‐9 expression and invasion of oral cancer cells 2009 ·Journal of Cellular Biochemistry ·Mathew J. Joseph, Surabhi Dangi‐Garimella, Mario A. Shields, (unknown), Limin Sun, Jennifer E. Koblinski, Hidayatullah G. Munshi	73
18	Prolyl Isomerase Cyclophilin A Regulation of Janus-Activated Kinase 2 and the Progression of Human Breast Cancer 2008 ·Cancer Research ·Jiamao Zheng, Jennifer E. Koblinski, (unknown), (unknown), Charles V. Clevenger	61
19	The laminin α-1 chain derived peptide, AG73, increases fibronectin levels in breast and melanoma cancer cells 2008 ·Clinical & Experimental Metastasis ·Jean A. Engbring, Rydhwana Hossain, (unknown), (unknown), Michael C. Wu, Suguru Hibino, Jennifer E. Koblinski	7
20	International hermelin brain tumor symposium on matricellular proteins in normal and cancer cell-matrix interactions 2004 ·Matrix Biology ·Timothy J. Bos, Susan L. Cohn, Jennifer E. Koblinski, (unknown), J E Murphy-Ullrich, Osvaldo L. Podhajcer, Sandra A. Rempel, Jeremy N. Rich, James T. Rutka, E. Helene Sage, Erik W. Thompson	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact